chloramphenicol has been researched along with scopolamine hydrobromide in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baker, CJ; Sastry, RV | 1 |
| Bron, A; Brown, N | 1 |
| Fisher, AA | 1 |
| Laibson, PR; Piebenga, LW | 1 |
| Ellis, PP | 1 |
| Gibson, MR; Gupta, MP | 1 |
| Bandle, EF; Cumin, R; Gamzu, E; Haefely, WE | 1 |
| BIETTI, G | 1 |
2 review(s) available for chloramphenicol and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systemic reactions to topical therapy.
Topics: Adult; Aged; Atropine; Carbachol; Child, Preschool; Chloramphenicol; Cholinesterase Inhibitors; Cocaine; Epinephrine; Glucocorticoids; Humans; Isoproterenol; Male; Ophthalmic Solutions; Parasympatholytics; Parasympathomimetics; Phenylephrine; Pilocarpine; Scopolamine; Tropanes | 1971 |
17 other study(ies) available for chloramphenicol and scopolamine hydrobromide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Endophthalmitis associated with Haemophilus influenzae type b bacteremia and meningitis.
Topics: Administration, Topical; Ampicillin; Atropine; Chloramphenicol; Cyclopentolate; Dexamethasone; Endophthalmitis; Female; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Injections, Intravenous; Male; Meningitis, Haemophilus; Microbial Sensitivity Tests; Neomycin; Ophthalmic Solutions; Phenylephrine; Polymyxin B; Prednisone; Scopolamine; Sepsis | 1979 |
Recurrent erosion of the cornea.
Topics: Adult; Aged; Chloramphenicol; Cornea; Corneal Diseases; Corneal Dystrophies, Hereditary; Cysts; Female; Humans; Male; Middle Aged; Phenols; Recurrence; Scopolamine; Sodium Chloride | 1976 |
Erythema multiforme-like eruptions due to topical medications: Part II.
Topics: Balsams; Chloramphenicol; Clioquinol; Drug Eruptions; Econazole; Erythema Multiforme; Ethylenediamines; Female; Furazolidone; Humans; Mafenide; Mephenesin; Middle Aged; Neomycin; Nitrofurans; Ointments; Promethazine; Scopolamine; Sulfonamides; Vitamin E | 1986 |
Dendritic lesions in herpes zoster ophthalmicus.
Topics: Aged; Chloramphenicol; Cornea; Diagnosis, Differential; Female; Herpes Zoster Ophthalmicus; Humans; Keratitis, Dendritic; Male; Middle Aged; Prednisolone; Scopolamine | 1973 |
Protein-alkaloid relationship in Datura stramonium var. tatula.
Topics: Alkaloids; Atropa belladonna; Carbon Isotopes; Chloramphenicol; Chromatography, Thin Layer; Cycloheximide; Datura stramonium; Nitrogen; Plant Proteins; Plants, Medicinal; Plants, Toxic; Proline; Puromycin; Scopolamine | 1972 |
Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.
Topics: Animals; Avoidance Learning; Brain; Carbon Dioxide; Chloramphenicol; Cycloheximide; Electric Stimulation; Electroshock; Learning; Male; Memory; Pyrrolidinones; Rats; Scopolamine | 1982 |
[THE TASK OF THE GENERAL PRACTITIONER IN EMERGENCY OPHTHALMOLOGIC WORK].
Topics: Acetazolamide; Anti-Bacterial Agents; Benzimidazoles; Chloramphenicol; Dichlorphenamide; Epinephrine; Eye Burns; Eye Injuries; Family Practice; General Practice; General Practitioners; Idoxuridine; Leucomycins; Niacin; Nicotinic Acids; Novobiocin; Ointments; Ophthalmology; Penicillins; Phenylephrine; Scopolamine; Streptomycin; Tetracycline | 1964 |